Abstract
Polymerase Chain Reaction (PCR) technology allows scientist to amplify, copy, identify, characterize and manipulate genes in a relatively simple way. Exploitation of the technology to devise new products and translate these to the commercial sector has been remarkable. Molecular technologies are not difficult to establish and use, and can appear to offer developing countries many opportunities. However, developing countries should look in a different way at the apparent advantages offered. Whilst molecular biological science appears to offer solutions to many problems, there are a number of drawbacks. This desire to adopt the latest technology often overrides any considerations of the use of more conventional technologies to address needs. The conventional, and often more practical, methods already provide many specific tools in the disease control area. Changing the technology can also deflect critical resources into the molecular field in terms of laboratory funding and training. This may cause redundancy of staff, limit further development in conventional techniques, and polarize scientists into the older (less glossy) and newer (molecular) camps.
Animal disease diagnosis still primarily utilizes conventional techniques such as Enzyme Linked Immunosorbent Assay (ELISA). This will not change drastically in developing countries, but developments will combine such methods with more discriminatory molecular techniques, and a balanced and parallel development is needed. An understanding of the use and possible advantages of the various technologies is required by both scientists and policy-makers in developing nations.
Vaccines based on molecular science could have a real impact in developing countries, but “vaccinology” needs to examine both the animal (immunology of target species) and the disease agent itself. This is a research-based science and, as such, is expensive, with no surety of success. Developing countries should exploit links with developed countries to provide the “field” genetic resource (endemic disease situation) in order to devise and test vaccines developed through molecular studies.
Development of technologies cannot be divorced from an understanding of the epidemiology of the diseases found in developing countries. This is frequently not undertaken due to the many competing demands on the scarce resources available. However, increased livestock trade possibilities may provide the focus and catalyst needed to ensure that animal health science is applied appropriately and usefully for the benefit of developing countries.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 IAEA
About this paper
Cite this paper
Crowther, J., Jeggo, M. (2005). Challenges and Opportunities for Controlling and Preventing Animal Diseases in Developing Countries through Gene-based Technologies. In: Makkar, H.P., Viljoen, G.J. (eds) Applications of Gene-Based Technologies for Improving Animal Production and Health in Developing Countries. Springer, Dordrecht. https://doi.org/10.1007/1-4020-3312-5_6
Download citation
DOI: https://doi.org/10.1007/1-4020-3312-5_6
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-3311-7
Online ISBN: 978-1-4020-3312-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)